Brief report · 30 Jun 2026
EditorialPublished 20 Aug 2020
Novel Anticancer Operators Show Guarantee to Control Tumor Development in Almost Every Disease Type
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A quality called MYC has gotten probably the most sweltering objective for disease specialists around the globe. MYC is known to drive tumor development in almost all disease types - however effectively focusing on the quality has demonstrated to be a test. One that has been astounding specialists for over three decades. Presently, scientists at Purdue University have found a novel arrangement of MYC advertiser G-quadruplex stabilizers that have shown anticancer action in human malignant growth cell societies. The revelation is distributed in the July 8 version of the Journal of the American Chemical Society.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sowmya Uttam”

